Hongbo Lu - 30 Sep 2024 Form 5 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Director
Signature
/s/Hongbo Lu
Issuer symbol
ARWR
Transactions as of
30 Sep 2024
Transactions value $
$62,176
Form type
5
Filing time
15 Nov 2024, 20:34:11 UTC
Previous filing
09 Oct 2025
Next filing
20 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARWR Common Stock Purchase $11,200 +400 +1.19% $28.00 34,080 22 Mar 2024 Direct F1
transaction ARWR Common Stock Purchase $23,375 +850 +2.49% $27.50 34,930 26 Mar 2024 Direct F1
transaction ARWR Common Stock Purchase $4,101 +150 +0.43% $27.34 35,080 02 Apr 2024 Direct F1
transaction ARWR Common Stock Purchase $12,500 +500 +1.43% $25.00 35,580 10 Apr 2024 Direct F1
transaction ARWR Common Stock Purchase $11,000 +500 +1.41% $22.00 36,080 18 Apr 2024 Direct F1
transaction ARWR Common Stock Gift $0 -5,650 -15.7% $0.000000 30,430 25 Sep 2024 Direct F2
holding ARWR Common Stock 5,650 30 Sep 2024 By spouse F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes previously reported restricted stock units, which are subject to certain vesting conditions.
F2 On September 25, 2024, the Reporting Person transferred 5,650 shares of the Issuer's common stock from a jointly-held retirement account to her spouse's individual retirement account for no consideration.